Segui
Metin Cetin
Metin Cetin
Email verificata su musc.edu
Titolo
Citata da
Citata da
Anno
Naked-eye fluorescent sensor for Cu (II) based on indole conjugate BODIPY dye
SO Tümay, E Okutan, IF Sengul, E Özcan, H Kandemir, T Doruk, M Çetin, ...
Polyhedron 117, 161-171, 2016
632016
ETS1 is coexpressed with ZEB2 and mediates ZEB2‐induced epithelial‐mesenchymal transition in human tumors
I Yalim‐Camci, P Balcik‐Ercin, M Cetin, G Odabas, N Tokay, AE Sayan, ...
Molecular carcinogenesis 58 (6), 1068-1081, 2019
322019
The ZEB2‐dependent EMT transcriptional programme drives therapy resistance by activating nucleotide excision repair genes ERCC1 and ERCC4 in colorectal …
R Sreekumar, H Al‐Saihati, M Emaduddin, K Moutasim, M Mellone, ...
Molecular Oncology 15 (8), 2065-2083, 2021
252021
Cancer stem cells in hepatocellular carcinoma
T Yagci, M Cetin, PB Ercin
Journal of gastrointestinal cancer 48, 241-245, 2017
202017
ROR1 expression and its functional significance in hepatocellular carcinoma cells
M Cetin, G Odabas, LR Douglas, PJ Duriez, P Balcik-Ercin, I Yalim-Camci, ...
Cells 8 (3), 210, 2019
172019
Improved targeting for photodynamic therapy via a biotin–phthalocyanine conjugate: Synthesis, photophysical and photochemical measurements, and in vitro cytotoxicity assay
P Balçik-Erçin, M Çetin, M Göksel, M Durmuş
New Journal of Chemistry 44 (8), 3392-3401, 2020
152020
Genome-wide analysis of endogenously expressed ZEB2 binding sites reveals inverse correlations between ZEB2 and GalNAc-transferase GALNT3 in human tumors
P Balcik-Ercin, M Cetin, I Yalim-Camci, G Odabas, N Tokay, AE Sayan, ...
Cellular Oncology 41, 379-393, 2018
132018
Hepatocellular carcinoma cells with downregulated ZEB2 become resistant to resveratrol by concomitant induction of ABCG2 expression
P Balcik-Ercin, M Cetin, I Yalim-Camci, T Uygur, T Yagci
Molecular Biology 54, 75-81, 2020
102020
Targeting TACC3 represents a novel vulnerability in highly aggressive breast cancers with centrosome amplification
O Saatci, O Akbulut, M Cetin, V Sikirzhytski, M Uner, D Lengerli, ...
Cell Death & Differentiation 30 (5), 1305-1319, 2023
92023
Plexin C1 marks liver cancer cells with epithelial phenotype and is overexpressed in hepatocellular carcinoma
G Odabas, M Cetin, S Turhal, H Baloglu, AE Sayan, T Yagci
Canadian Journal of Gastroenterology and Hepatology 2018, 2018
92018
External complexation of BODIPYs by CB [7] improves in-cell fluorescence imaging
MM Ayhan, E Özcan, F Alkan, M Çetin, İ Ün, D Bardelang, B Çoşut
Materials Advances 3 (1), 547-553, 2022
72022
Naphthalimide-BODIPY dyads: Synthesis, characterization, photophysical properties, live cell imaging and antimicrobial effect
H Eserci, M Çetin, F Aydınoğlu, ET Eçik, E Okutan
Journal of Molecular Structure 1265, 133440, 2022
62022
Doxorubicin induces prolonged DNA damage signal in cells overexpressing DEK isoform-2
E Özçelik, A Kalaycı, B Çelik, A Avcı, H Akyol, İB Kılıç, T Güzel, M Çetin, ...
Plos one 17 (10), e0275476, 2022
22022
Behavior of HepG2 liver cancer cells using microfluidic-microscopy: A preliminary study
H Karamahmutoglu, M Çetin, T Yağcı, M Elitaş
Microfluidics, BioMEMS, and Medical Microsystems XVI 10491, 142-146, 2018
22018
Toxic PARP trapping upon cAMP-induced DNA damage reinstates the efficacy of endocrine therapy and CDK4/6 inhibitors in treatment-refractory ER+ breast cancer
O Saatci, M Cetin, M Uner, UM Tokat, I Chatzistamou, PG Ersan, ...
Nature Communications 14 (1), 6997, 2023
12023
Reviving immunogenic cell death upon targeting TACC3 enhances T-DM1 response in HER2-positive breast cancer
ME Gedik, O Saatci, N Oberholtzer, M Uner, O Akbulut, M Cetin, M Aras, ...
bioRxiv, 2023
12023
Psychological, endocrine and polygenic predictors of emotional well-being during the COVID-19 pandemic in a longitudinal birth cohort
T Nguyen, L Zillich, M Cetin, ASM Hall, JC Foo, L Sirignano, J Frank, ...
Stress 26 (1), 2234060, 2023
12023
Antibacterial and cytotoxic performance of methenamine‐based poly (lactic acid)/poly (ethylene glycol)(PLA/PEG) composite films
M Dandan Doganci, E Doganci, H Balci, M Cetin
Journal of Applied Polymer Science 141 (21), e55412, 2024
2024
Abstract PO3-28-12: Targeting the KCa3. 1 potassium channel arrests ER+ breast cancer growth and re-sensitizes to drug resistance
D Delisi, M Cetin, O Saatci, O Sahin, S Gentile
Cancer Research 84 (9_Supplement), PO3-28-12-PO3-28-12, 2024
2024
Abstract PO4-23-10: Restoring the efficacy of standard of care in treatment-refractory ER+ breast cancer by re-activation of cAMP-ROS-DNA damage axis
O Saatci, M Cetin, M Uner, UM Tokat, I Chatzistamou, PG Ersan, ...
Cancer Research 84 (9_Supplement), PO4-23-10-PO4-23-10, 2024
2024
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20